We would love to hear your thoughts about our site and services, please take our survey here.
It was a press release of the article that has been doing the rounds of late:
https://www.ophthalmologytimes.com/view/n4-pharma-moving-novel-delivery-systems-towards-commercialization
“Non-viral, non-lipid delivery systems are in high demand in the exciting gene therapy and oncology spaces and we now have two such delivery systems,” Nigel Theobald, CEO of N4 Pharma, said in the company’s news release. “Nuvec continues to show its versatility as a novel delivery system and with LipTide we are developing our first commercial product which we are aiming to take into phase 1 clinical trials.”
'The company will now engage in discussions with the FDA and MHRA to approve a GLP toxicity study and first in human clinical trials.'
Phil did mention in the presentation that he thought it would be difficult for a takeover offer to get voted through due to the large shareholdings of Bosch and Weichai. If either Bosch / Weichai however wanted to make a bid, then who knows...
Its fantastic news that the NED's are buying.
Annoys me when people complain about the £'s purchased. The 2 NED's have bough £45k/27k respectively. These are not huge amounts but they may will already have money invested elsewhere and probably have NED positions with other companies. Just because they are NED's it does not mean they have 6/7 figures lying around under the sofa with which to go balls deep on every company they're associated with....